Objectives: To describe and compare the prescribing of antibiotics used for urinary tract infections and its correlation with resistance in Escherichia coli in urinary samples across two adjacent regions-the Capital Region and the Skaane Region-and their municipalities in Denmark and Sweden.
Introduction
Antibiotic prescribing in primary care in Europe varies greatly, 1 not only between countries, but also between regions within the same country. 2 Antibiotic consumption is associated with the development of antimicrobial resistance at both the individual and community levels. 2 Denmark and Sweden are neighbouring countries and general practice accounts for about 75% and 63% of their total antibiotic consumption, respectively. 3, 4 The Capital Region in Denmark and the Skaane Region in Sweden are among the regions with the highest use of antibiotics in the two countries. 4, 5 The two regions are adjacent and connected by a bridge.
Two decades ago, the Skaane Region had a 33% higher consumption of antibiotics, as measured by DDDs, compared with the Capital Region. 6 No recent study has compared antibiotic prescription in the two regions but the overall use of antibiotics in Denmark and Sweden shows that the pattern has changed significantly. Whereas there has been a 42% decrease in the total consumption of antibiotics in Sweden from 1992 to 2015, 4 overall antibiotic consumption in Denmark has increased by 38% from 1996 to 2015, though it seems to have stagnated during the last few years. 7 In 2015, the total consumption of antibiotics in outpatient care was 511 prescriptions/1000 inhabitants in Denmark and 349 prescriptions/1000 inhabitants in Sweden. 4, 7 Worldwide, a suspected urinary tract infection (UTI) is the second-most common reason to prescribe antibiotics in outpatient care and accounts for about 10%-15% of all antibiotic prescriptions in outpatient care. 8, 9 The annual incidence of UTIs among women aged 18 years is estimated to be 10.8%-13.3%. 10, 11 The most common pathogen involved in UTI is Escherichia coli, which accounts for 75%-90% of all reported cases. 12 In both countries, UTIs are primarily treated with pivmecillinam. 13, 14 The two adjacent regions are quite comparable regarding their primary healthcare organizations, choice of antibiotics and access to laboratory testing, yet these regions have notably different antibiotic consumption rates. It is not known whether the differences in antibiotic prescribing rates are reflected in different antibiotic resistance rates at the regional and municipal levels.
The aim of this study is to compare antibiotic prescribing and antibiotic resistance rates in E. coli from urine cultures of women aged 18 years at the regional and municipal levels. Furthermore, this study also assesses the correlation between antibiotic prescribing and E. coli resistance at the municipal level.
Methods

Study areas and population
The Oresund strait borders the Capital Region on its west side and the Skaane Region on its east side ( Figure 1 ). The Capital Region is one of five regions in Denmark and consists of 29 municipalities, the largest of which is Copenhagen. The Skaane Region is one of 21 regions in Sweden and consists of 33 municipalities, the largest of which is Malmö. The Capital Region and the Skaane Region had 725 960 and 515 668 female inhabitants aged 18 years, respectively, on 31 December 2014 (www.dst.dk and www.scb.se).
Data on antibiotic prescription
From 1 January to 31 December 2014, antibiotic prescription data from outpatient care [general practitioners (GPs) and from hospital doctors to ambulant or discharged patients] were provided from a central pharmacy settlement system in each region. From both databases aggregated data on dispensed products according to the WHO Anatomical Therapeutic Chemical (ATC J01) classification were extracted. The aggregated data were subdivided at the municipal level. 15 All data were quantified in terms of technical units for comparison: number of prescriptions/1000 women/ year, number of DDDs/1000 women/year and DDDs/prescription.
Data on antibiotic resistance
Urinary samples from women aged 18 years that were registered in the laboratory databases at each Department of Clinical Microbiology from 1 January to 31 December 2015 were included. Data on bacteria and antimicrobial resistance were obtained from the laboratory information system, WWLab (Autonik, Sweden), which was used at the Department of Clinical Microbiology in both regions. All E. coli isolates from urinary samples from outpatient care were included. Significant growth was defined as the growth of 10 3 cfu/mL. When multiple identical isolates from the same patient occurred within a 30 day period, only the first isolate was used. Identification of E. coli was performed using approved conventional methods 16 and susceptibility testing was performed by disc diffusion methods according to EUCAST recommendations. 17 The susceptibility testing was comparable for the two regions regarding pivmecillinam, trimethoprim and nitrofurantoin. Comparing the prescribing rate of ciprofloxacin was relevant for the aim of the study, but could not be performed owing to different methods of susceptibility testing; the Capital Region uses nalidixic acid as a marker for ciprofloxacin resistance, whereas the Skaane Region uses ciprofloxacin. In Sweden, the national treatment recommendations for lower UTIs in women aged .18 years recommend pivmecillinam at 200 mg % 3 for 5 days or nitrofurantoin at 50 mg % 3 for 5 days as first-choice antibiotics and trimethoprim at 160 mg % 2 as the second choice after culture. 13 In Denmark, the following are recommended for 3-5 days as first-choice antibiotics: pivmecillinam at 400 mg % 3, trimethoprim at 200 mg % 2 or sulfamethizole at 1000 mg % 2.
14 It has been advocated that it is optimal to include a time lag when analysing the association between antibiotic use and antibiotic resistance. To date, it is not clear what the best-fitting model is, but studies have found that resistant strains are detectable from 1 to 12 months after exposure to antibiotics. 18, 19 This study created a dataset combining antibiotic prescription data from 2014 and resistance data from 2015.
Analysis
Aggregated data were analysed at the regional and municipal level. Descriptive statistics are presented as numbers, means, medians and IQRs. Resistance rates for pivmecillinam, trimethoprim and nitrofurantoin among E. coli isolates from urinary samples were calculated as the number of resistant isolates/total number of tested isolates. Correlation analyses were performed in order to evaluate linear associations between the municipal antibiotic prescribing and antibiotic resistance rates. Spearman's correlation coefficient with two-tailed significance was used when data from the Capital Region and the Skaane Region were analysed and compared as they formed non-normally distributed data; Pearson's correlation coefficient was used when the two regions were analysed separately. Correlation analyses were not performed on nitrofurantoin owing to the low number of nitrofurantoin-resistant E. coli. Independent t-tests were performed to analyse differences in mean values in antibiotic prescribing rates (DDDs and number of prescriptions) and differences in antibiotic resistance between municipalities. Table 1 shows the distribution of demographic factors, use of antibiotics and antibiotic-resistant strains in women aged 18 years in the Capital Region of Denmark and the Skaane Region of Sweden.
Results
Description of antibiotic use and resistance
Overall, the antibiotic prescribing rates of pivmecillinam, trimethoprim and nitrofurantoin were significantly higher in the Capital Region than in the Skaane Region, as were the resistance rates; when measured as the numbers of prescriptions, nitrofurantoin prescribing rates were significantly higher in the Skaane Region (Table 2 ).
Pivmecillinam
The use of pivmecillinam expressed in prescriptions/1000 women 18 years/year was 74% higher in the Capital Region than in the Skaane Region (Table 2) . Expressed in DDDs/1000 women/year, the use of pivmecillinam in the Capital Region was 220% of that used in the Skaane Region and the proportion of DDDs/prescription was about twice as high. The resistance rate to pivmecillinam was low in both regions, but it was significantly higher in the Capital Region (3.5% compared with 1.9% in the Skaane Region).
Trimethoprim
The use of trimethoprim expressed in prescriptions/1000 women 18 years/year was 142% higher in the Capital Region than in the Skaane Region (Table 2) . Expressed in DDDs, the use of trimethoprim is more than three times higher in the Capital Region than in the Skaane Region. In DDDs/prescription, the use was higher in the Capital Region (12.4 DDDs versus 8.3). The resistance rate to trimethoprim was also significantly higher in the Capital Region (27.1% compared with 14.2% in the Skaane Region).
Nitrofurantoin
The use of nitrofurantoin expressed in prescriptions/1000 women 18 years/year was close to twice as high in the Skaane Region compared with the Capital Region ( Table 2 ). The difference in nitrofurantoin consumption between the two regions was reduced and equalized when measured by DDDs/1000 women. DDDs/prescription were twice as high in the Capital Region compared with the Skaane Region. The resistance rate to nitrofurantoin was very low, but it was significantly higher in the Capital Region (1.3%) compared with the Skaane Region (0.3%).
Correlations between UTI-related antibiotic prescription and resistance rates at the municipal level Analyses at the municipal level showed considerable variations in antibiotic prescription and resistance rates within each region (Figures 2 and 3) . The total amount of pivmecillinam varied from 52.2 to 89.3 prescriptions/1000 women/year in municipalities in the Skaane Region and there was a positive significant correlation between the prescribing rate of pivmecillinam and the pivmecillinam resistance rate. In the Capital Region, the variation ranged from 97.8 to 142; the correlation was not statistically significant (Table 3) . Correlation analyses between the use of DDDs/1000 women/year and the resistance rate were significantly positive in the Skaane Region, but not in the Capital Region. A non-stratified correlation analysis with all the municipalities in both regions showed a positive significant correlation between the prescribing rate of pivmecillinam (DDDs/1000 women/year) and the resistance rate (Table 3) .
The prescribing rate of trimethoprim varied from 5.4 to 26.3 prescriptions/1000 women/year in municipalities in the Skaane Region and the resistance rate varied from 5.8% to 19.6%. In the Capital Region, the prescribing rate of trimethoprim varied from 11.0 to 45.7 prescriptions/1000 women/year between the municipalities and the resistance rate varied from 21.5% to 34.8%. The Skaane Region and the Capital Region both had slightly negative, but insignificant, correlations when measured as the number of prescriptions, as well as when measured as DDDs (Table 3) . Nonstratified analyses with all municipalities in both regions showed positive and significant correlations between the prescribing rate of trimethoprim as DDDs/1000 women/year and the resistance rate.
The prescribing rate of nitrofurantoin expressed as prescriptions/1000 women/year varied from 36.7 to 71.0 between municipalities in the Skaane Region and the resistance rate varied from 0.0% to 4.3%. In the Capital Region, the prescribing rate of nitrofurantoin expressed as prescriptions/1000 women/year varied from 21.7 to 50.9 and the resistance rate varied from 0.0% to 3.3%. Regional comparison of antibiotic prescribing and resistance
JAC
Owing to the low number of resistant isolates, no correlation analyses were made.
Discussion
This study compared the prescribing rates of pivmecillinam, trimethoprim and nitrofurantoin and the resistance rates in urine isolates of E. coli among women aged 18 years in two adjacent regions: the Capital Region in Denmark and the Skaane Region in Sweden. Overall, there was a significantly higher prescribing rate of antibiotics and a higher level of resistance in the Capital Region. Also, DDDs/prescription were significantly higher in the Capital Region. A correlation between antibiotic use and resistance at the municipal level was not found. Large differences were found in total antibiotic consumption between municipalities. The differences found in this study are noteworthy. The two regions are geographically closely situated and quite comparable, being regions in welfare states with similar climates and economic development. Both regions have a highly developed healthcare sector, including high access to GPs and hospitals and similar drug regulatory and supply systems. There is no reason to assume that the overall prevalence of UTIs among women differs between the two regions. This emphasizes that the prescribing of antibiotics for UTIs may be influenced by factors other than the occurrence of E. coli in the urine. One explanatory factor may be the differences in national treatment recommendations. According to the ATC J01 classification, 1 DDD for pivmecillinam is 600 mg, for trimethoprim is 400 mg and for nitrofurantoin is 200 mg. This means that the Capital Region recommends 2 DDDs of pivmecillinam, 1 DDD of trimethoprim and 1 DDD of nitrofurantoin for the treatment of UTI as compared with 1 DDD of pivmecillinam, 0.8 DDD of trimethoprim and 0.75 DDD of nitrofurantoin in the Skaane Region. It is not known why the recommendations differ between the two regions, but the subject may benefit from further investigation because adherence to different guidelines probably affects the resistance rates.
It is a well-known phenomenon that countries rank differently in antibiotic consumption depending on whether their use is expressed as DDDs or number of prescriptions. 20 DDDs may be a useful indicator when measuring the total antibiotic selection pressure, but DDDs might not address the differences in doses and treatment lengths between countries.
1 From a clinical perspective, it has been argued that a well-suited measure for antibiotic use in general practice is the number of prescriptions, as it is related to the decision to prescribe antibiotics and the number of individuals treated. 3, 18 In this study, pivmecillinam and trimethoprim use was even higher in the Capital Region, compared with the Skaane Region, when measured in DDDs instead of the number of prescriptions. The use of nitrofurantoin was almost twice as high in the Skaane Region compared with the Capital Region when measured in prescriptions, but when measured as DDDs the amount was only slightly higher. Women aged 18 years in the Capital Region received more antibiotics/prescription for UTIs as doctors Nygaard Jensen et al.
in the Capital Region generally prescribe a higher amount of DDDs/prescription for all three antibiotics. These results are in accordance with a recent Danish study that found that, for each treatment episode, the number of DDDs has increased during a 10 year period owing to increased pack size, longer duration of treatment or higher doses. 3 It is not known to what extent all the dispensed medicine has been taken as the data are based on sales information but it is hypothesized that compliance does not differ between the two regions.
The association between antibiotic use and antibiotic resistance has been generally accepted. 2 In our study, we found a positive and significant correlation between antibiotic use and antibiotic resistance when all the Danish and Swedish municipalities were analysed as one sample. However, when the regions were stratified, no correlations were found between antibiotic use and resistance at the municipal level in the Capital Region. In the Skaane Region, negative as well as positive associations were found between antibiotic use and resistance. It is known that about one-third of the published studies do not find strong positive associations between antibiotic use and resistance. 2 Several factors might explain this lack of a direct relationship, such as small studies, 2 aggregated data that do not link individual exposures and outcomes, 21 the Regional comparison of antibiotic prescribing and resistance JAC influence of transferred resistant bacteria from animals to humans 22 or co-selection, in which the use of one antibiotic selects for resistance to another antibiotic. 2 The lack of an association between antibiotic use and resistance in this study could be explained by the preceding factors; however, it could also be hypothesized that other factors within the countries should be taken into account. The reasons for large variations between the municipalities in the two regions are unknown. In order to explain differences between the municipalities, further research may benefit from adding possible influencing factors to the analyses on individual and municipal levels, such as socioeconomic and sociodemographic factors as well as practice-related factors. 23, 24 Furthermore, it should be revealed whether certain age groups have a more prominent use of antibiotics within each region. Further research may benefit from looking at possible structural factors that influence or are responsible for the large differences between countries.
Rational use of antibiotics and the development of new knowledge has been a special target for Sweden since 1994; in Sweden, the Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (Strama) has achieved a reduction in antibiotic use through a coordinated Nygaard Jensen et al.
educational effort. 25 In Denmark, no such national programme exists. The coordinated national effort made by Strama is probably the reason for the decline in antibiotic use in Sweden in the last two decades. 25, 26 Multidisciplinary regional Strama groups work in close collaboration with the regional drug and therapeutics committees, whose main intervention is education and training among GPs. One part of the education and training programme is to provide feedback to the GPs on their prescribing habits versus those of their peers. The feedback takes place in educational group discussions with colleagues. The individual prescriptions of antibiotics are presented openly in order to reflect and compare prescription patterns. In Denmark, GPs do not benchmark to the same extent, but can receive individual feedback from a medical consultant and the number of prescriptions is kept anonymously for other GPs apart from the individual GP. National recommendations should be investigated as an explanatory factor regarding the observed regional differences.
A limitation of the study is the inadequate reporting of how much time elapsed between the exposure to antibiotics and the appearance of resistant strains. Due to the use of yearly aggregated data-antibiotic consumption in 2014 and antibiotic resistance in 2015-this study lacks information on the precise interval between antibiotic prescribing and the occurrence of a resistant strain. The imprecise interval might reduce or increase the association; however, to date, it is not known what the optimal time lag is. 18 The number of women with UTIs and a urine culture in the two regions is based on valid information from the laboratory system; however, it is not known to what extent the severity of the UTIs (clinical symptoms, resistance pattern) has an impact on the decision to send a urine sample to the clinical microbiology laboratories in the two regions. In Denmark, local GPs can perform testing in their own practice. It is not known to what extent this is done, but it has been claimed that GPs in Denmark typically examine uncomplicated urine samples on their own. In Sweden, it is claimed that GPs treat uncomplicated UTIs without testing the urine and only send urinary samples to the laboratory in complicated cases. Whether differences in the rates of testing the urinary samples in the clinical microbiology laboratories in Denmark and Sweden may bias the resistance rate has not been investigated. It seems to some extent that both regions have selection bias as the majority of urinary samples tested in the clinical microbiology laboratories are from complicated cases of UTIs. Therefore, resistance rates may be comparable as it seems that GPs in both regions send samples to the laboratory from the more complicated UTIs but this has not been investigated.
Data on antibiotic resistance are derived from routine diagnostic samples sent for testing at clinical microbiology laboratories. To the best of our knowledge, we assume that the susceptibility testing follows EUCAST recommendations in the laboratories in both regions and thereby makes the comparison of resistance data valid, but there may be small differences in the routine that we are not aware of.
Conclusions
There were large differences in antibiotic prescribing rates and the prevalence of resistant strains in the two closely related Nordic regions: the Capital Region, Denmark and the Skaane Region, Sweden. Overall, there was a significantly higher rate of antibiotic prescribing in the Capital Region and a higher prevalence of resistant strains. No correlation between antibiotic use and resistance was found at the municipal level, when the two regions were analysed separately. It is notable that the DDD is higher per prescription in the Capital Region. There may be a number of aspects that influence differences in antibiotic use and it seems that regional guidelines are an important driver and explanatory factor for the variations in the consumption of pivmecillinam, trimethoprim and nitrofurantoin. The current study indicates that more antibiotic stewardship efforts are needed in the Capital Region, but future studies should also aim at revealing other mechanisms, such as structural factors as well as practice-related and socioeconomic factors that create the large differences between the two regions.
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